International Clinical Trial: Study on the incidence of venous thromboembolism in patients with locally advanced or metastatic NSCLC harboring EGFR-sensitive mutations treated with befotertinib with or without rivaroxaban

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119885) titled 'Study on the incidence of venous thromboembolism in patients with locally advanced or metastatic NSCLC harboring EGFR-sensitive mutations treated with befotertinib with or without rivaroxaban' on March 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College

Condition: non-small cell lung cancer

Intervention: Stage 1: Befotertinib monotherapy:Befotertinib for the treatment of patients with EGFR sensitive mutations in locally advanced or metastatic NSCLC Stage 1: Befotertinib combi...